Sixth Street Partners Management Company »

Aeglea Biotherapeutics shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $58M 653k 88.78

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics